Cargando…

Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice

Bisphosphonates and the anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody denosumab are effective anti-resorptive drugs commonly prescribed for osteoporosis. Both drugs may, however, have intolerable side effects; so, it is critical to examine their residual efficacy such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Omiya, Toshinobu, Hirose, Jun, Omata, Yasunori, Tominari, Tsukasa, Inada, Masaki, Watanabe, Hisato, Miyamoto, Takeshi, Tanaka, Sakae
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7305378/ https://www.ncbi.nlm.nih.gov/pubmed/32577437 http://dx.doi.org/10.1016/j.bonr.2020.100289

Ejemplares similares

Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice
por: Tokuyama, Naoto, et al.
Publicado: (2015)

Effect of risedronate on bone loss at discontinuation of denosumab
por: Laroche, Michel, et al.
Publicado: (2020)

Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways
por: Zhang, Bo, et al.
Publicado: (2019)

Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo
por: Lee, Chang Gun, et al.
Publicado: (2021)

Anti-Osteoporotic Mechanisms of Polyphenols Elucidated Based on In Vivo Studies Using Ovariectomized Animals
por: Niwano, Yoshimi, et al.
Publicado: (2022)

Dried Pomegranate Potentiates Anti-Osteoporotic and Anti-Obesity Activities of Red Clover Dry Extracts in Ovariectomized Rats
por: Kang, Su Jin, et al.
Publicado: (2015)

Transcription Factor Hematopoietically Expressed Homeobox Protein (Hhex) Negatively Regulates Osteoclast Differentiation by Controlling Cyclin‐Dependent Kinase Inhibitors
por: Watanabe, Hisato, et al.
Publicado: (2022)

In Vivo Screening for Anti-Osteoporotic Fraction from Extract of Herbal Formula Xianlinggubao in Ovariectomized Mice
por: Wang, Xinluan, et al.
Publicado: (2015)

Anti-Osteoporotic Effects of Antioxidant Peptides PIISVYWK and FSVVPSPK from Mytilus edulis on Ovariectomized Mice
por: Oh, Yunok, et al.
Publicado: (2020)

Does Panchatikta ghrita have anti-osteoporotic effect? Assessment in an experimental model in ovariectomized rats
por: Munshi, Renuka, et al.
Publicado: (2021)

Identification of Nedd9 as a TGF-β-Smad2/3 Target Gene Involved in RANKL-Induced Osteoclastogenesis by Comprehensive Analysis
por: Omata, Yasunori, et al.
Publicado: (2016)

Retraction: Effect of Pre- and Post-Surgery Treatment with Risedronate on Trabecular Bone Loss in Ovariectomized Rats
por: IWAMOTO, Jun, et al.
Publicado: (2018)

Protective effect of low-dose risedronate against osteocyte apoptosis and bone loss in ovariectomized rats
por: Ye, Tingjun, et al.
Publicado: (2017)

Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
por: Cho, Yong Ho, et al.
Publicado: (2020)

Anti-Osteoporotic and Anti-Adipogenic Effects of the Water Extract of Drynaria roosii Nakaike in Ovariectomized Mice Fed a High-Fat Diet
por: Jang, Seon-A, et al.
Publicado: (2019)

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance
por: Ke, Cheng‐hui, et al.
Publicado: (2021)

Anti-Osteoporotic Effects of Angelica sinensis (Oliv.) Diels Extract on Ovariectomized Rats and Its Oral Toxicity in Rats
por: Lim, Dong Wook, et al.
Publicado: (2014)

Anti-Osteoporotic Effect of Lactobacillus brevis AR281 in an Ovariectomized Mouse Model Mediated by Inhibition of Osteoclast Differentiation
por: Yu, Jing, et al.
Publicado: (2022)

Retraction: Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol.
por: IWAMOTO, Jun, et al.
Publicado: (2018)

Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
por: Yano, Tetsuo, et al.
Publicado: (2017)

Effects of risedronate, alendronate, and minodronate alone or in combination with eldecalcitol on bone mineral density, quality, and strength in ovariectomized rats
por: Yano, Tetsuo, et al.
Publicado: (2021)

Synergic Action of Systemic Risedronate and Local Rutherpy in Peri-implantar Repair of Ovariectomized Rats: Biomechanical and Molecular Analysis
por: Inoue, Bruna Kaori Namba, et al.
Publicado: (2023)

Efficacy of teriparatide compared with risedronate on FRAX(®)-defined major osteoporotic fractures: results of the VERO clinical trial
por: Body, J.-J., et al.
Publicado: (2020)

Scopolin Attenuates Osteoporotic Bone Loss in Ovariectomized Mice
por: Park, Eunkuk, et al.
Publicado: (2020)

Anti-osteoporotic effects of mixed compositions of extracellular polymers isolated from Aureobasidium pullulans and Textoria morbifera in ovariectomized mice
por: Cho, Chang-Soo, et al.
Publicado: (2018)

Anti-Osteoporotic Effects of Combined Extract of Lycii Radicis Cortex and Achyranthes japonica in Osteoblast and Osteoclast Cells and Ovariectomized Mice
por: Park, Eunkuk, et al.
Publicado: (2019)

Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study
por: Tutaworn, Teerapat, et al.
Publicado: (2023)

From discovery of RANKL to clinical application of anti-human RANKL antibody
por: Yasuda, Hisataka, et al.
Publicado: (2012)

Risedronate Attenuates Podocyte Injury in Phosphate Transporter-Overexpressing Rats
por: Asada, Yohei, et al.
Publicado: (2019)

Clinical development of anti-RANKL therapy
por: Schwarz, Edward M, et al.
Publicado: (2007)

The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis
por: Shiraishi, Ayako, et al.
Publicado: (2009)

Perioperative alendronate, risedronate, calcitonin and indomethacin treatment alters femoral stem fixation and periprosthetic bone mineral density in ovariectomized rats
por: Cankaya, Deniz, et al.
Publicado: (2015)

Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
por: Chen, Xiao, et al.
Publicado: (2017)

Tetrandrine Prevents Bone Loss in Ovariectomized Mice by Inhibiting RANKL-Induced Osteoclastogenesis
por: Zhong, Zeyuan, et al.
Publicado: (2020)

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
por: Chung, Yoon-Sok, et al.
Publicado: (2009)

Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction
por: Tanaka, Yoshiya, et al.
Publicado: (2020)

Bone Mineral Density Loss and Fracture Risk After Discontinuation of Anti-osteoporotic Drug Treatment: A Narrative Review
por: Elbers, Laura P. B., et al.
Publicado: (2021)

Intermittent Parathyroid Hormone Alters Gut Microbiota in Ovariectomized Osteoporotic Rats
por: Zhou, Jiaming, et al.
Publicado: (2022)

PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice
por: Choi, Joo-Hee, et al.
Publicado: (2018)

Astilbin prevents bone loss in ovariectomized mice through the inhibition of RANKL‐induced osteoclastogenesis
por: Jin, Haiming, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_aml2m5jefrd4acqfrq9v2pfoij